Infusion Pumps Market Remunerative Scenario by 2025
Infusion pumps are devices that permeate nutrients, fluids, or medications into the circulatory system of a patient’s body. In general, it is used intravenously in most of the cases. However, epidural, subcutaneous, and arterial infusions are also being used in quite a few cases. The credit of the infusion pumps go to the way these pumps can administer fluids. It is not all feasible and expensive for a trained nurse to administer medication, nutrients, or fluids into a patient’s body in a way that infusion pump does.
For instance, infusion pumps can infuse as little as 0.1 mL per hour injection or injection with repeated boluses or an injection per minute as per the requests made by the patient. It can give injections up to a maximum number of times per hour, for instance, in cases of patient controlled analgesia and it can also vary the fluids as and when required by the patients. Infusion pumps are capable of creating immense pressure but at the same time they are able to control pressure as well. These pumps are used to inject regulated amount of fluids just beneath the skin or subcutaneously as it is commonly known as. Epidural is another method that is used by infusion pumps to inject fluids just in the surface of the central nervous system, for this method is implemented while administering local anesthesia to pregnant woman during childbirth.
Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1793
Infusion Pumps Market: Overview
An infusion pump is a medical device designed to deliver fluids or drugs into a patient’s body in an administered and controlled manner; fluids may include nutrients or different types of medications such as insulin, hormones, pain relievers, antibiotics, and chemotherapy drugs. The devices can be powered mechanically or electrically and can be used in a variety of clinical settings.
The market has evolved rapidly driven by a steady demand for different types of infusion pumps—stationary and ambulatory infusion pumps—for the management of a wide range of ailments that include cancer, diabetes, gastrointestinal diseases, neurological disorders, and AIDS. Over the past few years, the infusion pumps market has witnessed growing popularity of various specialized types such as enteral feeding pumps, patient-controlled analgesia (PCA) pump, and insulin pumps among patients. Manufacturers of medical devices are constantly making efforts to increase the reliability and safety of infusion pumps and to reduce medication errors delivered by intravenous infusion.
Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1793
Infusion Pumps Market: Trends
The infusion pumps market is primarily driven by the increasing incidence of various chronic diseases, the management of which requires safe and controlled administration of medications and drugs. In addition, the increasing number of surgeries performed in developed and developing regions and a rise in geriatric population are expected to fuel the market. The increasing inclination toward the adoption of alternative therapies for the treatment of cancer, multiple sclerosis, congestive pain, rheumatoid arthritis, and chronic pain has stimulated the demand for infusion pumps. For instance, the adoption of intrathecal drug delivery is emerging as a viable option for the treatment of patients suffering from chronic and intractable pain or severe spasticity.
Coupled with this, constant automation and technological advancements in infusion devices and accessories have led to the availability of smart infusion pumps with ergonomic design, enhanced operation, user-friendly interfaces, and portability, thereby propelling the market.
Infusion Pumps Market: Market Potential
The increased adoption of insulin pumps for the self-management of diabetes across home settings and the adoption of implantable infusion systems for neurological diseases are developments expected to expand the potential of the infusion pumps market.
Read Comprehensive Overview of Report @ https://www.tmrresearch.com/infusion-pumps-market
Flowonix Medical Inc., a pioneer in drug delivery systems company based in New Jersey, and Cerebral Therapeutics, a company based in Colorado, have announced the world’s first clinical trial administering medication directly into the brain of patients suffering from refractory epilepsy. The two companies jointly developed Prometra II Programmable Pump, an implantable infusion pump, to be used with an intrathecal catheter for the affected patients in the Australian Direct Drug Administration for Refractory Epilepsy (ADDRESS) clinical trial conducted at St. Vincent's Hospital, Australia. The wide ranging clinical study will enable the companies to assess the efficacy of micro-infusion therapy featuring the intracerebroventricular (ICV) delivery of the drug—valproate sodium—among patients with intractable epilepsy.
The study, believes the participants will have profound ramifications in the potential of implantable infusion therapies for the treatment of drug-resistant uncontrollable epilepsy and is expected to benefit the healthcare community at large. Although the Prometra II Pump is not yet approved for the ICV administration of valproate in the U.S. and Australia, the clinical study opens up promising options.
Infusion Pumps Market: Regional Outlook
Among major regions, North America is a prominent market for infusion pumps and is expected to exhibit impressive growth along the forecast period. The significant growth in the regional market is attributable to the rising penetration of high-end pumps, soaring adoption of ambulatory pumps for managing chronic diseases, and the presence of a robust healthcare infrastructure. In addition, the increased integration of infusion therapy in healthcare IT infrastructure has propelled the regional market.
The Asia Pacific market is anticipated to witness substantial growth along the forecast period. A rapid rise in geriatric population, increasing accessibility of healthcare facilities, advances in health insurance sector, and a rise in chronic diseases are the factors fuelling the regional market.
Infusion Pumps Market: Competitive Analysis
Several companies are offering technologically advanced infusion therapies, including implantable, wearable, and automated infusion pumps, to help the management of a wide range of chronic diseases. Major players operating in the infusion pumps market include B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Pfizer Inc., Medtronic, Terumo Corporation, and Roche Diagnostics.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infusion Pumps Market Remunerative Scenario by 2025 here
News-ID: 1024103 • Views: 452
More Releases from TMR Research
Sepsis Diagnostics Market Scope, Segmentation, Development and Opportunities wit …
Sepsis Diagnostics Market: Overview The increasing prevalence of sepsis and the rising awareness about the availability of its treatment is a primary factor boosting the global sepsis diagnostics market and is likely to continue doing so in the coming years as well. Sepsis is a genuine condition coming about because of the presence of hurtful microorganisms in the blood or different tissues and the body’s reaction to their essence, possibly prompting
Genomics Market Newer Segments of Application 2030
Introduction: Genomics refers to the study of structure, function and inheritance of the genome of an organism. Genomic technology offer opportunities to improve healthcare across the breadth of medical specialities. It uses a combination of recombinant DNA, DNA sequencing methods and bioinformatics to sequence, assemble and analyse the structure and function of genomes. Genomics focuses on the interaction between loci and allels within the genome and other interactions such as epistasis,
Gene Expression Market Expansion Projected to Gain an Uptick During 2030
Gene Expression Market: Overview The rise in target patient population is considered a key factor boosting the global gene expression market and likely to continue doing so in the forecast period set between 2020 and 2030. The diminishing expense of sequencing strategies and the accessibility of gene expression data sets are relied upon to fuel the development of the market in the coming years. The significant development in the advancement of
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Poised to Garner Maximum Reve …
Digital PCR (dPCR) and Real-time PCR (qPCR) Market: Overview The increasing cases of infectious diseases are a prime factor augmenting the growth of the global digital PCR and real-time PCR market during the forecast period set between 2020 and2030. The increasing geriatric population, coupled with the rising number of genetic disorders is also propelling growth of this market. Furthermore, the persistent mechanical headways in PCR advances, the fruitful fulfillment of the
More Releases for Infusion
Beacon Infusion Opens New Infusion Location in Hackensack, NJ
PRESS INFORMATION FOR IMMEDIATE RELEASE: July 17, 2020 Contact: Beacon Infusion Healthcare Services www.beaconinfusion.com 833-223-2266 Beacon Infusion Opens New Infusion Location in Hackensack, NJ Rapid growth and expanding patient base accelerate need for new locations HACKENSACK, NJ JULY 17, 2020 – Beacon Infusion Healthcare Services, a pioneer in national freestanding infusion centers providing infusion and long-acting injectable care, announces the addition of a brand-new location to serve its growing patient base. This is Beacon Infusion’s second location in New
Global Infusion Pump Market Insights, Forecast
Traditional medical infusion pumps are employed in a range of applications and settings from basic fluids for hydration to administering pain medications and antibiotics. Such pumps have been used in long-term care settings, hospitals, physician’s offices, and home settings. This can be further broken out to uses specifically in the emergency department, operating room, and neonate department. This device is a high-interest area for several companies, given the aging of
Infusion Pumps Market – Latest Developments
Infusion Pumps Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Infusion Pumps market research report is a professional and in-depth study on the current state of Infusion Pumps Industry. The Infusion Pumps Market research report covers the present scenario and the growth prospects of
Modular infusion pump tester reduces „down time“
Nuremberg, June 29, 2018 : GOSSEN METRAWATT, supplier of measuring and testing technology, presents the SECULIFE IFPRO, a new modular analysis system for infusion pumps. The high-precision, easy-to-use system has full touchscreen control of all processes without the use of old-fashioned keys and buttons. The 7" colour touch screen display can be infinitely adjusted for optimum operation and readability. The highlight of the SECULIFE IFPRO is the new, innovative,
Infusion System Market: Global Snapshot by 2025
Global Infusion system Market is projected to grow at a CAGR of 4.9% and is expected to reach US$ 44333.5 million by 2025. Globally, North America accounted for the largest market share in 2016. Global Infusion system is one of the fastest market. The global infusion systems market is segmented on the basis of applications which comprises of chemotherapy, diabetes, gastrointestinal, pediatrics, and others. The Global Infusion system market comprises
Infusion Pumps Market | Market Growth Analysis 2019
The global infusion systems market is projected to reach around US$7.7 bn by the end of 2019, after being recorded at US$5.4 bn in 2012. The market is progressing at a CAGR of 5.30% from 2013 to 2019, according to a research report released by Transparency Market Research. The research report, titled “Infusion Pumps Market (Large Volume, Disposable, Syringe, Ambulatory, Implantable) - Global Industry Analysis, Size, Share, Growth, Trends and